# Acellular Dermal Matrix(SureDerm BCS) in Breast-Conserving Surgery for Breast Cancer Patients

> **NCT07345026** · NA · NOT_YET_RECRUITING · sponsor: **Seoul St. Mary's Hospital** · enrollment: 116 (estimated)

## Conditions studied

- Breast Neoplasms
- Mastectomy, Segmental

## Interventions

- **DEVICE:** Acellular Dermal Matrix (SureDerm BCS)
- **PROCEDURE:** Standard Breast-Conserving Surgery

## Key facts

- **NCT ID:** NCT07345026
- **Lead sponsor:** Seoul St. Mary's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-08
- **Primary completion:** 2027-10-01
- **Final completion:** 2028-04-30
- **Target enrollment:** 116 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07345026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07345026, "Acellular Dermal Matrix(SureDerm BCS) in Breast-Conserving Surgery for Breast Cancer Patients". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT07345026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*